ASCO21 - Highlights longkanker

Koos van der Hoeven bespreekt met Egbert Smit ontwikkelingen bij longkanker. Aan bod komen onder andere adjuvante en neo-adjuvante immunotherapieën voor gevorderd NSCLC, nieuwe behandelmogelijkheid voor KRAS-gemuteerde, gevorderde NSCLC en behandeling voor osimertinibresistente tumoren.

Episode metadata supplied by the publisher feed · Published Jun 9, 2021

Embed this episode

Attribution link and audio player

Ready to play

ASCO21 - Highlights longkanker

0:00 30:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncologie.nu?

This episode is 30 minutes long.

When was this Oncologie.nu episode published?

This episode was published on June 9, 2021.

Can I download this Oncologie.nu episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!